Throne Jason 4
4 · IDEAYA Biosciences, Inc. · Filed Nov 7, 2023
Insider Transaction Report
Form 4
Throne Jason
VP, General Counsel
Transactions
- Sale
Common Stock
2023-11-03$30.09/sh−5,163$155,360→ 0 total - Exercise/Conversion
Common Stock
2023-11-03$12.86/sh+5,163$66,396→ 5,163 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-11-03−5,163→ 48,750 totalExercise: $12.86Exp: 2032-02-29→ Common Stock (5,163 underlying)
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 29, 2023.
- [F2]This transaction was executed in multiple trades in prices ranging from $30.00 to $30.23, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.